Annual Total Liabilities
$73.77 M
+$11.65 M+18.75%
December 31, 2023
Summary
- As of February 8, 2025, RCKT annual total liabilities is $73.77 million, with the most recent change of +$11.65 million (+18.75%) on December 31, 2023.
- During the last 3 years, RCKT annual total liabilities has fallen by -$13.54 million (-15.51%).
- RCKT annual total liabilities is now -15.51% below its all-time high of $87.31 million, reached on December 31, 2020.
Performance
RCKT Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$63.92 M
+$2.14 M+3.47%
September 30, 2024
Summary
- As of February 8, 2025, RCKT quarterly total liabilities is $63.92 million, with the most recent change of +$2.14 million (+3.47%) on September 30, 2024.
- Over the past year, RCKT quarterly total liabilities has increased by +$6.24 million (+10.82%).
- RCKT quarterly total liabilities is now -33.75% below its all-time high of $96.48 million, reached on March 31, 2021.
Performance
RCKT Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
RCKT Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +18.8% | +10.8% |
| 3 y3 years | -15.5% | +10.8% |
| 5 y5 years | +28.8% | +10.8% |
RCKT Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +74.4% | -13.3% | +51.1% |
| 5 y | 5-year | -15.5% | +74.4% | -33.8% | +51.1% |
| alltime | all time | -15.5% | +1536.4% | -33.8% | +1651.6% |
Rocket Pharmaceuticals Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $63.92 M(+3.5%) |
| Jun 2024 | - | $61.78 M(+6.6%) |
| Mar 2024 | - | $57.94 M(-21.5%) |
| Dec 2023 | $73.77 M(+18.7%) | $73.77 M(+27.9%) |
| Sep 2023 | - | $57.68 M(-1.9%) |
| Jun 2023 | - | $58.81 M(+5.2%) |
| Mar 2023 | - | $55.88 M(-10.0%) |
| Dec 2022 | $62.12 M(+46.9%) | $62.12 M(+24.4%) |
| Sep 2022 | - | $49.95 M(+13.1%) |
| Jun 2022 | - | $44.16 M(+3.8%) |
| Mar 2022 | - | $42.53 M(+0.6%) |
| Dec 2021 | $42.30 M(-51.6%) | $42.30 M(-5.1%) |
| Sep 2021 | - | $44.58 M(-2.5%) |
| Jun 2021 | - | $45.72 M(-52.6%) |
| Mar 2021 | - | $96.48 M(+10.5%) |
| Dec 2020 | $87.31 M(+34.7%) | $87.31 M(-6.8%) |
| Sep 2020 | - | $93.66 M(+8.2%) |
| Jun 2020 | - | $86.54 M(-0.2%) |
| Mar 2020 | - | $86.70 M(+33.7%) |
| Dec 2019 | $64.82 M | $64.82 M(-4.7%) |
| Sep 2019 | - | $67.99 M(+12.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2019 | - | $60.22 M(-7.4%) |
| Mar 2019 | - | $65.06 M(+13.6%) |
| Dec 2018 | $57.28 M(+6.0%) | $57.28 M(+11.5%) |
| Sep 2018 | - | $51.36 M(+1.7%) |
| Jun 2018 | - | $50.50 M(+7.4%) |
| Mar 2018 | - | $47.02 M(-13.0%) |
| Dec 2017 | $54.01 M(-4.4%) | $54.01 M(+0.8%) |
| Sep 2017 | - | $53.58 M(+0.1%) |
| Jun 2017 | - | $53.53 M(-2.1%) |
| Mar 2017 | - | $54.66 M(-3.2%) |
| Dec 2016 | $56.48 M(+1152.9%) | $56.48 M(+2.5%) |
| Sep 2016 | - | $55.09 M(+1149.9%) |
| Jun 2016 | - | $4.41 M(-11.2%) |
| Mar 2016 | - | $4.96 M(+10.1%) |
| Dec 2015 | $4.51 M(-92.1%) | $4.51 M(+23.5%) |
| Sep 2015 | - | $3.65 M(-81.7%) |
| Jun 2015 | - | $19.97 M(-7.4%) |
| Mar 2015 | - | $21.57 M(-62.2%) |
| Dec 2014 | $57.08 M(+10.3%) | $57.08 M(+547.6%) |
| Sep 2014 | - | $8.81 M(-83.0%) |
| Dec 2013 | $51.76 M(+60.0%) | $51.76 M |
| Dec 2012 | $32.35 M | - |
FAQ
- What is Rocket Pharmaceuticals annual total liabilities?
- What is the all time high annual total liabilities for Rocket Pharmaceuticals?
- What is Rocket Pharmaceuticals annual total liabilities year-on-year change?
- What is Rocket Pharmaceuticals quarterly total liabilities?
- What is the all time high quarterly total liabilities for Rocket Pharmaceuticals?
- What is Rocket Pharmaceuticals quarterly total liabilities year-on-year change?
What is Rocket Pharmaceuticals annual total liabilities?
The current annual total liabilities of RCKT is $73.77 M
What is the all time high annual total liabilities for Rocket Pharmaceuticals?
Rocket Pharmaceuticals all-time high annual total liabilities is $87.31 M
What is Rocket Pharmaceuticals annual total liabilities year-on-year change?
Over the past year, RCKT annual total liabilities has changed by +$11.65 M (+18.75%)
What is Rocket Pharmaceuticals quarterly total liabilities?
The current quarterly total liabilities of RCKT is $63.92 M
What is the all time high quarterly total liabilities for Rocket Pharmaceuticals?
Rocket Pharmaceuticals all-time high quarterly total liabilities is $96.48 M
What is Rocket Pharmaceuticals quarterly total liabilities year-on-year change?
Over the past year, RCKT quarterly total liabilities has changed by +$6.24 M (+10.82%)